drugset / Trial / NCT02469454

Effect of t of the Etonogestrel Releasing Implant on Infant Growth and Development

NCT02469454

Phase 4 Completed 100 enrolled University of Sao Paulo
RandomizedParallel-groupSingle-blind

Summary

This study aims to assess whether there is change in the growth and development of newborns whose mothers will have a etonogestrel (ENG) releasing implant inserted in the first 24 to 48 hours of delivery compared with those with standard implant insertion (6 week postpartum).

Timeline

Start
2015-06
Primary completion
2016-08
Completion
2016-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Etonogestrel Unknown Subcutaneous

Indications

No indication recorded.